Check the

BEST CELLARS (NW) LIMITED

Company
BEST CELLARS (NW) LIMITED (05565241)

BEST CELLARS (NW)

Phone: 07921 710 563
B⁺ rating

KEY FINANCES

Year
2017
Assets
£34.94k ▲ £0.33k (0.94 %)
Cash
£0k ▼ £0k (NaN)
Liabilities
£40.82k ▼ £-4.03k (-8.98 %)
Net Worth
£-5.89k ▼ £4.35k (-42.51 %)

REGISTRATION INFO

Company name
BEST CELLARS (NW) LIMITED
Company number
05565241
Status
Active
Categroy
Private Limited Company
Date of Incorporation
15 Sep 2005
Age - 19 years
Home Country
United Kingdom

CONTACTS

Website
bestcellarsnw.co.uk
Phones
07921 710 563
Registered Address
EGERTON HOUSE,
HOOLE ROAD,
CHESTER,
CH2 3NJ

ECONOMIC ACTIVITIES

43290
Other construction installation

THIS BUSINESS IN SOCIAL MEDIA

Facebook
View
Google Plus
Visit
Twitter
Follow

LAST EVENTS

28 Feb 2017
Total exemption small company accounts made up to 31 August 2016
10 Oct 2016
Confirmation statement made on 15 September 2016 with updates
18 Feb 2016
Total exemption small company accounts made up to 31 August 2015

See Also


Last update 2018

BEST CELLARS (NW) LIMITED DIRECTORS

Louise Yvonne Nesbitt

  Acting
Appointed
12 February 2007
Role
Secretary
Address
Egerton House, Hoole Road, Chester, United Kingdom, CH2 3NJ
Name
NESBITT, Louise Yvonne

Louise Yvonne Nesbitt

  Acting
Appointed
30 April 2007
Occupation
Director
Role
Director
Age
55
Nationality
British
Address
Egerton House, Hoole Road, Chester, United Kingdom, CH2 3NJ
Country Of Residence
United Kingdom
Name
NESBITT, Louise Yvonne

Roy Christopher Nesbitt

  Acting PSC
Appointed
15 September 2005
Occupation
Director
Role
Director
Age
56
Nationality
British
Address
Egerton House, Hoole Road, Chester, United Kingdom, CH2 3NJ
Country Of Residence
United Kingdom
Name
NESBITT, Roy Christopher
Notified On
6 April 2016
Nature Of Control
Ownership of shares – 75% or more

Anthony Joseph Flynn

  Resigned
Appointed
15 September 2005
Resigned
12 February 2007
Role
Secretary
Address
83 Daleside, Upton, Chester, CH2 1EW
Name
FLYNN, Anthony Joseph

REVIEWS


Check The Company
Very good according to the company’s financial health.